- About Us
- Consensus Meeting
- Join Our Coalition
- Contact Us
The National Prescription Drug Abuse Prevention Policy Consensus Meeting has consistently been among the most substantively focused and effective gatherings nationwide to unite the diverse stakeholders who must work together to reduce prescription drug abuse.
The annual National Prescription Drug Abuse Prevention Policy Consensus Meeting brings together health care professionals, educators, legislators, law enforcement, insurers, private companies, journalists, academics, and nonprofits in search of the best ideas for reducing prescription drug abuse while optimizing patient care.
On November 19, 2013, the National Prescription Drug Abuse Prevention Policy Consensus Meeting met for sixth time in Washington D.C.
This year’s meeting included substantial discussions on the following topics:
The Center for Lawful Access and Abuse Deterrence (CLAAD), the nonprofit policy group behind the meeting, works to foster greater coordination among groups which often worked simultaneously but not together: private companies, nonprofit groups, and government policy makers.
CLAAD’s policy positions are established through a consensus process, in which at least 80 percent of the participants must represent not-for-profit organizations. This rule of governance ensures that the public interest drives CLAAD’s priorities, as opposed to the interests of individual stakeholders.
Over the past six years, CLAAD has orchestrated a unified vision to address prescription drug abuse. Lists of participants in the 2008 – 2013 meetings can be found on the Consensus Meeting website under the Participants tab. This year, thirty organizations met and achieved remarkable progress working together.
Yet, much more remains to be done.
At next year’s meeting, a select group of seven socially responsible private companies will have a rare opportunity that goes far beyond a series of lectures. They will forge relationships with practitioners, nonprofits, government representatives, commercial coalition members, and more. Participants will not need to jockey for attention from the influential leaders that will attend this 40-person meeting.
The need for action is pressing. Drug overdoses rank as a leading cause of accidental human death in the U.S., but sound policy, coordinated activity, and evidence-based technology can save lives.
For more information on the National Prescription Drug Abuse Prevention Policy Consensus Meeting sponsorship opportunities, contact us at (202) 599-8435 or email us at email@example.com.